ArticleFrontiers in medicine2026
Naringenin restores neuronal membrane electro-biophysical homeostasis: insights from EIS circuit modeling and molecular dynamics.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Naringenin (NGN), a bioactive flavonoid derived from Citri Reticulatae Pericarpium, exhibits considerable neuroprotective properties. However, the precise mechanisms underlying its restoration of neuronal membranes during oxidative stress remain elusive. Methods: This study utilized an integrated multiscale approach combining network pharmacology, electrical impedance spectroscopy (EIS) with an eight-element equivalent circuit model, biochemical assays, and molecular dynamics (MD) simulations to systematically evaluate NGN's effects on H2O2-induced injury in HT22 neurons. Results: EIS analysis revealed that NGN significantly restored membrane biophysical integrity, reflected by the recovery of critical electro-biophysical parameters (Rm, Cm and fc1) at subcellular resolution. Concurrently, biochemical analyses showed that NGN activates the NRF2/HO-1 signaling pathway, resulting in elevated superoxide dismutase (SOD) activity and decreased malondialdehyde (MDA) levels, thereby enhancing endogenous antioxidant defenses. Furthermore, molecular docking and MD simulations confirmed at the atomic level that NGN forms highly stable, high-affinity complexes with core antioxidant and anti-apoptotic targets, including NRF2, HO-1, and BCL-2. Discussion: These findings collectively indicate that NGN exerts a dual neuroprotective mechanism involving both biochemical antioxidant defense and biophysical membrane restoration. Integrating traditional pharmacology with modern biophysical modeling, this study positions EIS as an innovative, label-free approach for monitoring membrane protection, thereby establishing an electrophysiology-based platform for both mechanistic investigation and clinical translation of flavonoids in neuroprotection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.